Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03189914
Title RX-3117 in Combination With Abraxane in Subjects With Metastatic Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Rexahn Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Rexahn Site Tucson Arizona 85724 United States Details
Rexahn Site Weeki Wachee Florida 34607 United States Details
Rexahn Site Joliet Illinois 60435 United States Details
Rexahn Site Skokie Illinois 60077 United States Details
Rexahn Site Lexington Kentucky 40503 United States Details
Rexahn Site Boston Massachusetts 02115 United States Details
Rexahn Site New York New York 10065 United States Details
Rexahn Site Spartanburg South Carolina 29303 United States Details
Rexahn Site Spokane Washington 99202 United States Details
Rexahn Site Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field